- Physician-led plan
- KPV as capsule or pen
- Pause or cancel any time
- Recovery & Repair
- Gut Health
- 12 weeks
Recover+
BPC-157 · TB-500 · KPV
For: injuries with ongoing inflammation, active people with gut issues
FromAED 300/ month
Order summary
- Full protocol
- [PRICE]
- Total
- [PRICE]
Prescription only. Your BioMax physician confirms the protocol is right for you on the call, and sets and adjusts every dose.
Overview
Everything in Recover, plus KPV, a three-amino-acid peptide studied for its ability to dampen NF-κB, one of the cell's main "on switches" for inflammation, especially in the gut. Designed for people whose recovery is held back by ongoing inflammation, or who want gut support alongside injury recovery.
What's inside
BPC-157
Pen- Dose
- 500 mcg daily
- How
- Combined pen, one injection a day
- Length
- 12 weeks
TB-500
Pen- Dose
- 666 mcg daily (about 4.7 mg
- How
- Same combined pen
- Length
- a week) 12 weeks
KPV
Pen- Dose
- 500 mcg daily
- How
- One capsule a day, or a small daily injection with its own pen
- Length
- 12 weeks
all three compounds weeks 1–12. Markers: gut inflammation often starts to settle in weeks 4–6; review call at the end of week 12.
Your 12 weeks
Every compound in a block starts and finishes together, with one review call at the end. Your physician tailors the schedule to you.
BPC-157, TB-500 and KPV all run in weeks 1 to 12. Gut inflammation often starts to settle in weeks 4 to 6, and there is a review call at the end of week 12.
What the research looks at
What researchers have measured so far. These are findings from studies, not promises of results.
New blood supply
In lab and animal studies, BPC-157 activated VEGFR2, the main receptor that tells blood vessels to grow into injured tissue.
Cell migration
Thymosin beta-4 helps repair cells and new blood vessel cells move into injured tissue, according to lab and animal studies.
Calms inflammatory signalling
In lab studies, KPV reduced NF-κB activity and the release of inflammatory cytokines in the cells lining the gut.
Works when taken by mouth
In animal models of colitis, oral KPV reduced inflammation and damage to the colon, and helped preserve the gut barrier.
Who shouldn't use it
- Active cancer or a history of cancer
- Pregnancy or breastfeeding
- Anyone under 18
- Known allergy to any ingredient
- Crohn's disease or ulcerative colitis: KPV is not a replacement for your treatment, so only with your specialist's agreement
Your physician reviews your health history on the call before anything is prescribed.
FAQ
Both give 500 mcg a day. The capsule needs no injection; the pen is a small daily injection with its own pen. Your physician will help you choose on the call.
Also in Recovery & Repair
Coming soon: Body Composition, Sexual Health and Skin & Hair
Not sure which protocol fits you?
A short assessment and a call with a DHA-licensed doctor.